Stockscreener 앱 받기
1.03
0.98%
0.01
전일 마감가:
$1.02
열려 있는:
$1.02
하루 거래량:
19,315
Relative Volume:
0.07
시가총액:
$37.94M
수익:
$63.15M
순이익/손실:
$-40.30M
주가수익비율:
-0.6168
EPS:
-1.67
순현금흐름:
$-44.47M
1주 성능:
+7.37%
1개월 성능:
-4.63%
6개월 성능:
-64.73%
1년 성능:
-78.18%
1일 변동 폭
$0.99
$1.04
1주일 범위
$0.90
$1.07
52주 변동 폭
$0.8645
$6.50
Tela Bio Inc Stock (TELA) Company Profile
명칭
Tela Bio Inc
전화
484-320-2930
주소
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
TELA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.01 | 37.94M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
132.40 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.40 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.09 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.59 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.42 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 개시 | Lake Street | Buy |
| 2019-12-03 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | JMP Securities | Mkt Outperform |
| 2019-12-03 | 개시 | Jefferies | Buy |
| 2019-12-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Tela Bio Inc 주식(TELA)의 최신 뉴스
Favourable Signals For TELA Bio: Numerous Insiders Acquired Stock - Yahoo Finance
JPMorgan Chase & Co. Increases Stock Holdings in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Geode Capital Management LLC Buys 136,890 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Renaissance Technologies LLC Has $1.28 Million Stake in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Critical Analysis: TELA Bio (NASDAQ:TELA) & Retractable Technologies (NYSE:RVP) - Defense World
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... - Yahoo
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with Strategic Initiatives - GuruFocus
TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN
TELA Bio to Announce First Quarter 2025 Financial Results | TELA Stock News - GuruFocus
TELA Bio to Announce First Quarter 2025 Financial Results - GlobeNewswire
Medical Tech Leader TELA Bio Schedules Q1 2025 Earnings: Key Growth Updates Expected - Stock Titan
TELA Bio, Inc. (NASDAQ:TELA) Stock Position Boosted by Commonwealth Equity Services LLC - Defense World
Prudential Financial Inc. Takes $57,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Tela Bio slumps after Q4 miss as Piper Sandler downgrades - MSN
TELA Bio Expands OviTex PRS Line with Larger Surgical Sizes - MSN
Canaccord maintains TELA Bio stock with $7 target post-challenges By Investing.com - Investing.com Canada
Canaccord maintains TELA Bio stock with $7 target post-challenges - Investing.com
Tela Bio stock plunges to 52-week low of $1.13 amid market challenges - Investing.com Canada
Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 50% - simplywall.st
TELA Bio introduces larger sizes for soft tissue reconstruction - Investing.com India
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery - GlobeNewswire
Revolutionary Expansion: TELA Bio's New OviTex PRS Sizes Set Industry Record as Sales Surge 31% - Stock Titan
TELA Bio’s Earnings Call: Challenges and Optimism for 2025 - MSN
TELA Bio (NASDAQ:TELA) Cut to “Neutral” at Piper Sandler - The AM Reporter
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook - MSN
TELA Bio’s SWOT analysis: biologic platform maker faces growth hurdles By Investing.com - Investing.com Canada
Canaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $7.00 - Defense World
TELA Bio (NASDAQ:TELA) Rating Lowered to “Neutral” at Piper Sandler - Defense World
TELA Bio (NASDAQ:TELA investor three-year losses grow to 88% as the stock sheds US$35m this past week - simplywall.st
TELA Bio Full Year 2024 Earnings: Revenues Disappoint - Yahoo Finance
TELA Bio, Inc. (NASDAQ:TELA) Q4 2024 Earnings Call Transcript - Insider Monkey
Tela Bio downgraded to Neutral from Overweight at Piper Sandler - TipRanks
TELA Bio’s SWOT analysis: biologic platform maker faces growth hurdles - Investing.com India
TELA Bio stock price target cut to $7 by Citizens JMP - Investing.com Canada
TELA Bio Inc. (TELA) reports earnings - Quartz
TELA Bio, Inc. SEC 10-K Report - TradingView
Sector Update: Health Care - TradingView
TELA Bio stock plunges to 52-week low of $1.9 amid market challenges - Investing.com India
TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover - Yahoo
TELA Bio’s Hold Rating: Challenges in Sales Force Turnover and Financial Outlook - TipRanks
Tela Bio stock falls as Piper downgrades on Q4 miss (TELA) - Seeking Alpha
Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result - Yahoo Finance
TELA Bio stock plunges to 52-week low of $1.9 amid market challenges By Investing.com - Investing.com South Africa
Earnings call transcript: Tela Bio Q4 2024 misses earnings, stock drops By Investing.com - Investing.com Australia
Tela Bio Inc (TELA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tela Bio Inc 주식 (TELA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
| KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
| Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jun 28 '24 |
Sale |
4.74 |
378,000 |
1,791,720 |
2,457,542 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 02 '24 |
Sale |
4.54 |
36,600 |
166,164 |
2,407,242 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 01 '24 |
Sale |
4.68 |
13,700 |
64,116 |
2,443,842 |
9.57%
0.08%
자본화:
|
볼륨(24시간):